DOCSLIB.ORG

82Nd AANS Annual Scientific Meeting Program Guide April 5–9, 2014 San Francisco, California #AANS2014

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
82Nd AANS Annual Scientific Meeting Program Guide April 5–9, 2014 San Francisco, California #AANS2014 82nd AANS Annual Scientific Meeting Program Guide April 5–9, 2014 San Francisco, California #AANS2014 Program Guide Last Updated: Feb. 21, 2014. Scan here to access the full AANS Annual Scientific Meeting App, or visit http://2014mtg.aans.org for the most up-to-date changes and information. TABLE OF CONTENTS WEEK-AT-A-GLANCE 3 2013 RECOGNITION 6 INVITED SPEAKERS AND AWARD RECIPIENTS 7 AANS AND ANCILLARY MEETING 15 SHUTTLE INFORMATION 22 PROGRAM 23 AANS RESOURCE CENTER 67 AANS EXHIBIT HALL 68 NEUROSURGERY RESEARCH AND EDUCATION FOUNDATION (NREF) 103 CANDIDATE AND MEDICAL STUDENT PROGRAMS 104 ADVANCED PRACTICE PROVIDERS PROGRAMS 105 SECTION ACTIVITIES 106 GENERAL INFORMATION 107 CONTINUING MEDICAL EDUCATION (CME) 112 DISCLOSURES 114 FLOOR PLANS 137 2 WWW.AANS.ORG/AANS2014 #AANS2014 WEEK AT A GLANCE Friday, April 4 5–7 p.m. AANS REGISTRATION – South Lobby of The Moscone Center Saturday, April 5 6:30 a.m.– 5:30 p.m. AANS REGISTRATION – South Lobby of The Moscone Center 8 a.m.–5 p.m. ALL-DAY PRACTICALS (#001–003) 8 a.m.–12 p.m. MORNING PRACTICAL CLINICS (#004–009) 1–5 p.m. AFTERNOON PRACTICAL CLINICS (#010–017) 3–5 p.m. SPEAKER READY ROOM – 252–256 Sunday, April 6 6:30 a.m.– 6:30 p.m. AANS REGISTRATION – South Lobby of The Moscone Center 7:30 a.m.–4:30 p.m. ALL-DAY PRACTICALS (#018–021) 7:30–11:30 a.m. MORNING PRACTICAL CLINICS (#022–029) 8:30–11:30 a.m. ADVANCED PRACTICE PROVIDERS PLENARY SESSION – 305 12:30–4:30 p.m. AFTERNOON PRACTICAL CLINICS (#030–038) 2–4:30 p.m. OSLER LECTURE FOR MEDICAL STUDENTS – 132–133 2:45–4:45 p.m. HOSPITAL EMPLOYMENT FOR NEUROSURGEONS: IS IT IN YOUR BEST INTEREST AND HOW DOES IT WORK? – 131 2:45–4:45 p.m. NEUROSURGEON AND RETIREMENT – 130 5–6:30 p.m. AANS OPENING CEREMONIES – 102–104 7–9 p.m. AANS OPENING RECEPTION AT THE EXPLORATORIUM Monday, April 7 6:30 a.m. – 4 p.m. AANS REGISTRATION – South Lobby of The Moscone Center 6:30 a.m. – 5 p.m. SPEAKER READY ROOM – 252–256 7–9 a.m. BREAKFAST SEMINARS 9–9:45 a.m. MORNING BREAK IN THE AANS EXHIBIT HALL – EXHIBIT HALLS ABC 9 a.m.–4 p.m. AANS EXHIBIT HALL – EXHIBIT HALLS ABC 9:45 a.m.–1 p.m. PLENARY SESSION I – 102–104 Rhoton Family Lecture: Christopher I. Shaffrey, MD, FAANS Theodore Kurze Lecture: Vinko Dolenc, MD, PhD Presidential Address: William T. Couldwell, MD, PhD, FAANS 3 WWW.AANS.ORG/AANS2014 #AANS2014 1–2 p.m. LUNCH IN THE AANS EXHIBIT HALL – EXHIBIT HALLS ABC 2–5:30 p.m. SCIENTIFIC SESSIONS I–VI Scientific Session I: Tumor – 307/309 Scientific Session II: Spine – 301/303 Scientific Session III: Sterotactic and Functional Surgery – 305 Scientific Session IV: Pediatrics – 308/310 Scientific Session V: Cerebrovascular – 302/304 Scientific Session VI: Neurotrauma and Critical Care – 306 2–5:30 p.m. INTERNATIONAL SYMPOSIUM I: EXPANDING GLOBAL NEUROSURGERY – 236–238 2–3:30 p.m. OPERATIVE NUANCES I: TACKLING CHALLENGING CASES – 134–135 3:30–4 p.m. AFTERNOON BREAK IN THE AANS EXHIBIT HALL – EXHIBIT HALLS ABC 5:30–6:30 p.m. JOINT ANNUAL BUSINESS MEETING OF THE AANS & THE AMERICAN ASSOCIATION OF NEUROSURGEONS – 300 6:30–8 p.m. AANS INTERNATIONAL RECEPTION AT THE ASIAN ART MUSEUM 6:30–8:30 p.m. DINNER SYMPOSIUM I: CONCUSSION AT SCALA’S BISTRO 6:30–8:30 p.m. DINNER SYMPOSIUM II: SPINAL BALANCE/DEFORMITY AT MCCORMICK & KULETOS 6:30–9:30 p.m. AANS HISTORY SECTION DINNER AT MARINES’ MEMORIAL CLUB & HOTEL 8–10 p.m. NREF FUNDRAISER IN HONOR OF CHARLES B. WILSON, MD, DSc, MSHA, FAANS(L) AT THE FILLMORE Tuesday, April 8 6:30 a.m.– 4 p.m. AANS REGISTRATION – South Lobby of The Moscone Center 6:30 a.m. – 5 p.m. SPEAKER READY ROOM – 252–256 7–9 a.m. BREAKFAST SEMINARS 9–9:45 a.m. MORNING BREAK IN THE AANS EXHIBIT HALL – EXHIBIT HALLS ABC 9 a.m.– 4 p.m. AANS EXHIBIT HALL – EXHIBIT HALLS ABC 9:45 a.m.–1 p.m. PLENARY SESSION II – 102–104 Hunt-Wilson Lecture: Robert Gates Cushing Oration: Clayton Christensen 1–2 p.m. LUNCH IN THE AANS EXHIBIT HALL – EXHIBIT HALLS ABC 2–5:30 p.m. SECTION SESSIONS AANS/CSNS Socioeconomic – 302/304 AANS/CNS Cerebrovascular Section – 301/303 AANS/CNS Section on Disorders of the Spine and Peripheral Nerves: Spine Section Session – 308/310 AANS/CNS Section on Neurotrauma and Critical Care – 306 AANS/CNS Section on Stereotactic and Functional Surgery – 305 AANS/CNS Section on Tumors I – 307/309 4 WWW.AANS.ORG/AANS2014 #AANS2014 2–5:30 p.m. INTERNATIONAL SYMPOSIUM II: AUSTRALIA-ASIA NEUROSURGICAL SUMMIT – 236–238 2–3:30 p.m. OPERATIVE NUANCES II: COMPLICATION AVOIDANCE – 134–135 3:30–4 p.m. AFTERNOON BREAK IN THE AANS EXHIBIT HALL – EXHIBIT HALLS ABC 6:30–8:30 p.m. DINNER SYMPOSIUM III: LOW GRADE GLIOMA AT EPIC ROASTHOUSE 6:30–8:30 p.m. DINNER SYMPOSIUM IV: MINIMALLY INVASIVE SURGERY AT FARALLON Wednesday, April 9 6:30 a.m. – 3:30 p.m. AANS REGISTRATION – South Lobby of The Moscone Center 6:30 a.m. – 5 p.m. SPEAKER READY ROOM – 252–256 7–9 a.m. BREAKFAST SEMINARS 9–9:45 a.m. MORNING BREAK IN THE AANS EXHIBIT HALL – EXHIBIT HALLS ABC 9 a.m.– 2:15 p.m. AANS EXHIBIT HALL – EXHIBIT HALLS ABC 9:45 a.m.–1 p.m. PLENARY SESSION III – 102–104 Louise Eisenhardt Lecture: Anne Marie Slaughter, M.Phil, D.Phil, JD Richard C. Schneider Lecture: Kevin T. Foley, MD, FAANS Van Wagenen Lecture: Ian F. Pollack, MD, FAANS 1–2 p.m. LUNCH IN THE AANS EXHIBIT HALL – EXHIBIT HALLS ABC 2–5 p.m. SECTION SESSIONS AANS Section on History of Neurological Surgery – 306 AANS/CNS Section on Pain – 305 AANS/CNS Section on Pediatric Neurological Surgery – 302/304 AANS/CNS Section on Disorders of the Spine and Peripheral Nerves: Peripheral Nerves Section Session – 308/310 AANS/CNS Section on Tumors II – 301/303 5 WWW.AANS.ORG/AANS2014 #AANS2014 2013 RECOGNITION Rhoton Family Lecture Theodore Kurze Lecture Distinguished Service AANS International Hunt-Wilson Lecture Cushing Medalist Christopher I. Shaffrey, Vinko Dolenc, MD, PhD Award Lifetime Recognition Robert Gates Troy M. Tippett, MD, MD, FAANS Plenary Session I Sir Graham Teasdale Award Plenary Session II FAANS Plenary Session I Monday, April 7 Plenary Session I Nicolas de Tribolet, MD Tuesday, April 8 Plenary Session II Monday, April 7 Monday, April 7 Plenary Session I Tuesday, April 8 Monday, April 7 Cushing Orator Ronald L. Bittner Louise Eisenhardt Richard C. Schneider Van Wagenen Lecture Humanitarian Award Clayton Christensen Lecture Lecture Lecture Ian F. Pollack, MD, Anselmo Pineda, MD, Plenary Session II Frederick F. Lang Jr., Anne-Marie Slaughter, Kevin T. Foley, MD, FAANS FAANS(L) Tuesday, April 8 MD, FAANS M.Phil, D.Phil, JD FAANS Plenary Session III Plenary Session III Scientific Session I: Tumor Plenary Session III Plenary Session III Wednesday, April 9 Wednesday, April 9 Tuesday, April 8 Wednesday, April 9 Wednesday, April 9 6 WWW.AANS.ORG/AANS2014 #AANS2014 INVITED SPEAKERS PLENARY SESSION I Monday, April 7 Rhoton Family Theodore Kurze AANS Lecture Lecture International Lifetime Recognition Award The Rhoton Family Lecture The Theodore Kurze Lecture is made possible thanks to is made possible thanks to an The AANS International Life- an endowment established endowment established by time Service Award recognizes by Albert L. Rhoton Jr., Dr. John J. and Mrs. Mary an international neurosurgeon MD, FAANS(L), in honor Guarnaschelli to honor and or other international dignitary of his family. recognize his mentor. for his or her lifetime of contri- butions to advancing the field of neurosurgery in a country outside Christopher I. Shaffrey, MD, FAANS, received his Vinko Dolenc, MD, PhD, is head of the neurosurgery the United States and Canada. medical degree from the University of Virginia and com- department of the University Medical Center Ljubljana pleted both neurosurgical and orthopaedics residencies in Slovenia, where he also earned his medical degree Nicolas de Tribolet, MD, studied at the medical school at the University of Virginia, followed by a spine fellowship in neurosurgery and his doctoral degree in science. of Lausanne, Switzerland, as well as in Paris. After com- in pediatric and adult reconstructive spine surgery. Dr. Dolenc is an active member of 23 national and pleting medical school,he started an internship in neuro- international neurosurgical associations. He organized surgery, clinical electro-physiology and neuropathology in After his postgraduate training, Dr. Shaffrey completed a the First International Symposium on Cavernous Sinus Lausanne. It was during his one-year fellowship at Massa- scholarship obligation to the United States Navy at Ports- in Ljubljana in 1986, and since then, has organized chusetts General Hospital that Dr. de Tribolet began his mouth Navy Medical Center. In 1997, he was appointed to and/or participated in numerous microanatomy hands- research on brain tumors, which, in the following years, the senior staff in the departments of neurological surgery on skull base intensive workshops. Twenty years after developed into a laboratory that currently employs 12 and orthopaedic surgery at Henry Ford Hospital. In 1999, the first International Symposium on Cavernous Sinus, full-time researchers. Appointed professor of neurosurgery Dr. Shaffrey was appointed associate professor of neurolog- he organized the second ISOCS in Ljubljana in 2006. and chairman of the department of neurosurgery of the ical surgery and adjunct associate professor of orthopaedic Dr.
Load more

Recommended publications
  • 2000 HSS/PSA Program 1
    HISTORY OF SCIENCE SOCIETY 2000 ANNUAL MEETING PHILOSOPHY OF SCIENCE ASSOCIATION 2000 BIANNUAL MEETING 2-5 November 2000 Vancouver, British Columbia, Canada Hyatt Regency Vancouver CONTENTS Acknowledgments 3 HSS Officers, Program Chairs, and Council 4 PSA Officers and Program Committee 5 General Information 6 HSS / PSA 2000 Annual Meeting Book Exhibit Layout 7 Floor Plans: Hyatt Regency Vancouver 8-9 Vancouver Points of Interest 10-13 Committees and Interest Groups 14-15 HSS Full Program Schedule 16-20 HSS 2000 Program 21-43 HSS Distinguished Lecture 40 HSS Abstracts 44-187 PSA Full Program Schedule 188-190 PSA 2000 Program 191-202 PSA President’s Address 197 PSA Abstracts 203-245 HSS/PSA Program Index 246-252 Advertisements 253 Cover Illustration: SeaBus riders get the best view of Vancouver from the water. Offering regular service on the busiest routes from 5 a.m. to 2 a.m. and late night owl service on some downtown suburban routes until 4:20 a.m., Greater Vancouver’s transit system--the bus, SkyTrain and SeaBus-- covers more than 1800 square kilometers (695 square miles) of the Lower Mainland. The SkyTrain, a completely automated light rapid transit system, offers direct, efficient service between downtown Vancouver and suburban environs. It follows a scenic elevated 29 kilometer (18 mile) route with 20 stations along the way. All the SkyTrain stations, except Granville, have elevators and each train is wheelchair accessible. The SkyTrain links with buses at most of the 20 stations and connects with the SeaBus in downtown Vancouver. It operates daily, every two to five minutes.
    [Show full text]
  • 2015 Annual Report
    ANNUAL REPORT 2015 MARCH 2016 TO OUR SHAREHOLDERS ALEX GORSKY Chairman, Board of Directors and Chief Executive Officer This year at Johnson & Johnson, we are proud this aligned with our values. Our Board of WRITTEN OVER to celebrate 130 years of helping people Directors engages in a formal review of 70 YEARS AGO, everywhere live longer, healthier and happier our strategic plans, and provides regular OUR CREDO lives. As I reflect on our heritage and consider guidance to ensure our strategy will continue UNITES & our future, I am optimistic and confident in the creating better outcomes for the patients INSPIRES THE long-term potential for our business. and customers we serve, while also creating EMPLOYEES long-term value for our shareholders. OF JOHNSON We manage our business using a strategic & JOHNSON. framework that begins with Our Credo. Written OUR STRATEGIES ARE BASED ON over 70 years ago, it unites and inspires the OUR BROAD AND DEEP KNOWLEDGE employees of Johnson & Johnson. It reminds OF THE HEALTH CARE LANDSCAPE us that our first responsibility is to the patients, IN WHICH WE OPERATE. customers and health care professionals who For 130 years, our company has been use our products, and it compels us to deliver driving breakthrough innovation in health on our responsibilities to our employees, care – from revolutionizing wound care in communities and shareholders. the 1880s to developing cures, vaccines and treatments for some of today’s most Our strategic framework positions us well pressing diseases in the world. We are acutely to continue our leadership in the markets in aware of the need to evaluate our business which we compete through a set of strategic against the changing health care environment principles: we are broadly based in human and to challenge ourselves based on the health care, our focus is on managing for the results we deliver.
    [Show full text]
  • Johnson & Johnson
    JOHNSON & JOHNSON FORM 10-K (Annual Report) Filed 02/22/13 for the Period Ending 12/30/12 Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK, NJ 08933 Telephone 732-524-2455 CIK 0000200406 Symbol JNJ SIC Code 2834 - Pharmaceutical Preparations Industry Biotechnology & Drugs Sector Healthcare Fiscal Year 12/12 http://www.edgar-online.com © Copyright 2013, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 30, 2012 Commission file number 1-3215 JOHNSON & JOHNSON (Exact name of registrant as specified in its charter) New Jersey 22-1024240 (State of incorporation) (I.R.S. Employer Identification No.) One Johnson & Johnson Plaza New Brunswick, New Jersey 08933 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (732) 524-0400 SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Title of each class Name of each exchange on which registered Common Stock, Par Value $1.00 New York Stock Exchange Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Manufacturers and Wholesalers Street
    Nevada AB128 Code of Conduct Compliant Companies Manufacturers and Wholesalers Street City ST Zip 10 Edison Street LLC 13 Edison Street LLC Abbott Diabetes Care Division Abbott Diagnostic Division Abbott Electrophysiology (including Kalila Medical 2- 2016)) Abbott Laboratories 100 Abbott Park Road, Dept. EC10, Bldg. APGA-2 Abbott Park IL 60064 Abbott Medical Optics Abbott Molecular Division Abbott Nutrition Products Division Abbott Vascular Division (includes Tendyne 9-2015) AbbVie, Inc. 1 N. Waukegan Road North Chicago IL 60064 Acadia Phamaceuticals 3611 Valley Centre Drive, Suite 300 San Diego CA 92130 Accelero Health Partners, LLC Acclarent, Inc. 1525-B O'Brien Dr. Menlo Park CA 94025 Accuri Cyometers, Inc. Ace Surgical Supply, Inc. 1034 Pearl St. Brockton MA 02301 Acorda Therapeutics, Inc. 420 Sawmill River Road Ardsley NY 10532 AcriVet, Inc. Actavis W.C. Holding, Inc. Morris Corporate Center III, 400 Interpace Parkway Parsippany NJ 07054 Actavis , Inc. Actelion Pharmaceuticals US, Inc. 5000 Shoreline Court, Suite 200 S. San Francisco CA 94080 Activis 400 Interpace parkway Parsippany NJ 07054 A-Dec, Inc. 2601 Crestview Dr. Newberg OR 97132 Advanced Respiratory, Inc. Advanced Sterilization Products 33 Technology Drive Irvine CA 92618 Advanced Vision Research, Inc., dba Akorn Consumer Health Aegerion Pharmaceuticals, Inc. 101 Main Street, Suite 1850 Cambridge MA 02142 Aesculap Implant Systems, Inc. Aesculap, Inc. 3773 Corporate Parkway Center Valley PA 18034 Aesthera Corporation Afaxys, Inc. PO Box 20158 Charleston SC 29413 AGMS, Inc. Akorn (New Jersey) Inc. Page 1 of 23 Pages 2/15/2017 Nevada AB128 Code of Conduct Compliant Companies Akorn AG (formerly Excelvision AG) Akorn Animal Health, Inc.
    [Show full text]
  • Towards the Creation of Polymer Composites Which Can Be
    TOWARDS THE CREATION OF POLYMER COMPOSITES WHICH CAN BE REFILLED WITH ANTIBIOTICS AFTER IMPLANTATION FOR INFECTION TREATMENT By ERIKA LEAH CYPHERT Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: Horst von Recum, Ph.D. Department of Biomedical Engineering CASE WESTERN RESERVE UNIVERSITY January 2021 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Erika Leah Cyphert Candidate for the Doctor of Philosophy degree*. (signed) Steven Eppell, Ph.D. (chair of committee) Horst von Recum, Ph.D. Eben Alsberg, Ph.D. Agata Exner, Ph.D. Jonathan Pokorski, Ph.D. (date) September 25, 2020 *We also certify that written approval has been obtained for any proprietary material contained therein. 2 To my grandparents with love – Phil and Ann Cyphert Ted and Dorothy Lippold Florence Miller 3 TABLE OF CONTENTS TABLE OF CONTENTS………………………………………………………………..4 LIST OF TABLES…………………………………………………………………..….10 LIST OF FIGURES…………………………………………………………………….13 LIST OF ABBREVIATIONS……………………………………………………….…21 ACKNOWLEDGEMENTS……………………………………………………………24 ABSTRACT…………………………………………………………………………..…27 CHAPTER 1: DIAGNOSIS AND BIOMATERIAL-BASED TREATMENTS FOR PERIPROSTHETIC JOINT INFECTIONS………………………………………….29 1.1. LIMITATIONS OF CLINICAL TREATMENT OF PERIPROSTHETIC INFECTION…………………………………………………………………30 1.1.1. INTRODUCTION…………………………………………….…30 1.1.2. ISOLATION OF MICROBIAL ORGANISMS………………....33 1.1.3. POSSIBLE UNDERLYING PATIENT COMORBIDITIES……33 1.1.4. BIOFILM FORMATION AND BACTERIAL RESISTANCE…34 4 1.1.5. REVISION PROCEDURES/INITIAL TREATMENT FAILURES....................................................................................36 1.1.6. SUMMARY……………………………………………………...37 1.2. NOVEL TREATMENT MODALITIES FOR PJIS………………………...38 1.2.1. LIMITATIONS WITH TRADITIONAL ANTIBIOTIC-LADEN PMMA BONE CEMENT……………………………………..…38 1.2.2. COMMERCIALLY AVAILABLE ALTERNATIVE BIOMATERIALS FOR ANTIBIOTIC-LADEN PMMA BONE CEMENT………………………………………………………...40 1.2.3.
    [Show full text]
  • Suzanne Fischer Dissertation
    Diseases of Men: Sexual Health and Medical Expertise in Advertising Medical Institutes, 1900-1930 A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Suzanne Michelle Fischer IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY Sally Gregory Kohlstedt August, 2009 © Suzanne Fischer 2009 This work is licensed under the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/us/ or send a letter to Creative Commons, 171 Second Street, Suite 300, San Francisco, California, 94105, USA. i Acknowledgements Many thanks to my advisor, Sally Gregory Kohlstedt and the members of my committee for their assistance. Thanks also to Susan Jones, Mike Sappol and others who provided guidance. Many archivists and librarians assisted my research, including Christopher Hoolihan at the Miner Medical Library, Elaine Challacombe and Jim Curley at the Wangensteen Historical Library, Elizabeth Ihrig at the Bakken, and the staff of the Archives of the American Medical Association. Many thanks to my father and to my late mother. Members of DAWGs, the Dissertation and Writers Group, including Susan Rensing, Margot Iverson, Juliet Burba, Don Opitz, Hyung Wook Park, Gina Rumore, Rachel Mason Dentinger, Erika Dirkse, Amy Fisher and Mike Ziemko provided helpful commentary. Many friends, including Katherine Blauvelt, Micah Ludeke, Mary Tasillo, Megan Kocher, Meghan Lafferty, Cari Anderson, Christine Manganaro and Josh Guttmacher provided support and dinner. And endless gratitude to my greatest Friend. ii Dedication This dissertation is dedicated to the memory of my mother, Barbara Fischer.
    [Show full text]
  • Annual Report
    ANNUAL REPORT 2019 MARCH 2020 To Our Shareholders Alex Gorsky Chairman and Chief Executive Officer By just about every measure, Johnson & These are some of the many financial and Johnson’s 133rd year was extraordinary. strategic achievements that were made possible by the commitment of our more than • We delivered strong operational revenue and 132,000 Johnson & Johnson colleagues, who adjusted operational earnings growth* that passionately lead the way in improving the health exceeded the financial performance goals we and well-being of people around the world. set for the Company at the start of 2019. • We again made record investments in research and development (R&D)—more than $11 billion across our Pharmaceutical, Medical Devices Propelled by our people, products, and and Consumer businesses—as we maintained a purpose, we look forward to the future relentless pursuit of innovation to develop vital with great confidence and optimism scientific breakthroughs. as we remain committed to leading • We proudly launched new transformational across the spectrum of healthcare. medicines for untreated and treatment-resistant diseases, while gaining approvals for new uses of many of our medicines already in the market. Through proactive leadership across our enterprise, we navigated a constant surge • We deployed approximately $7 billion, of unique and complex challenges, spanning primarily in transactions that fortify our dynamic global issues, shifting political commitment to digital surgery for a more climates, industry and competitive headwinds, personalized and elevated standard of and an ongoing litigious environment. healthcare, and that enhance our position in consumer skin health. As we have experienced for 133 years, we • And our teams around the world continued can be sure that 2020 will present a new set of working to address pressing public health opportunities and challenges.
    [Show full text]
  • Neurosurgeon Harvey Cushing—Was Bound And
    A DiligentBy Lee A. Witters, M.D. Effort n April 26, 1638—18 years after the One of the giants of Mayflower’s departure for the New World —the 350-ton Diligent of Ipswich set sail 20th-century medicine— from Gravesend, England. Captained by John Mar- Otin, the ship carried 133 passengers. The Diligent made landfall on August 10 in Boston, then pro- neurosurgeon Harvey ceeded immediately to Hingham, Mass., a South Shore town founded just five years earlier. Among the passengers who disembarked and settled there Cushing—was bound and were Matthew Cushing and Henry Smith. What kind of relationship they had with each determined to pay homage other, if any, is not part of recorded history. But the lives of a direct descendant of each—Dr. Harvey Williams Cushing, the father of neurosurgery and a to a seminal American pioneer in endocrinology, and Dr. Nathan Smith, the founder of Dartmouth Medical School—were physician who lived a century destined to connect 300 years later. Both Nathan Improve, Perfect, Smith and Harvey Cushing were giants of Ameri- &P can medicine in their own time, Smith in the ear- before him—Dartmouth erpetuate ly 19th century and Cushing in the early 20th cen- Dr. Nathan Smith tury. Proof of the confluence of their careers lies in Medical School founder and Early American documents in the Dartmouth archives and in a Medical Education bronze plaque that now adorns a hallway in the Remsen Building at Dartmouth Medical School. Nathan Smith. It’s a saga filled At the unveiling of that plaque on June 17, 1929, Harvey Cushing explained that by the 1700s, Oliver S.
    [Show full text]
  • Annals of Medical History Published Quarterly
    ANNALS OF MEDICAL HISTORY PUBLISHED QUARTERLY Volume V, No. 4 DECEMBER, 1923 Serial No. 20 EDITOR FRANCIS R. PACKARD, M.D., Philadelphia, Pa. ASSOCIATE EDITORS HORACE MANCHESTER BROWN, M.D. Milwaukee HARVEY CUSHING, M.D.............................................................. Boston CHARLES L. DANA, M.D........................................................ New York * GEORGE DOCK, M.D..................................................................Pasadena FIELDING H. GARRISON, M.D.........................................Washington HENRY BARTON JACOBS, M.D........................................... Baltimore HOWARD A. KELLY, M.D....................................................... Baltimore THOMAS McCRAE^ M.D.......................................................Philadelphia LEWIS STEPHEN PILCHER, M.D......................................... Brooklyn SIR D’ARCY POWER, K.B.E., F.R.C.S. (ENG.) F.S.A. London DAVID RIESMAN, M.D........................................................ Philadelphia JOHN RUHRAH, M.D.................................................................Baltimore CHARLES SINGER, M.D................................................................ Oxford EDWARD C. STREETER, M.D....................................................Boston CASEY A. WOOD, M.D................................................................. Chicago WINTER NUMBER NEW YORK PAUL B. HOEBER, INC., PUBLISHERS 67-69 EAST 59th STREET ANNALS OF MEDICAL HISTORY Volume V, No. 4 DECEMBER, 1923 Serial No. 20 / Original articles are published only
    [Show full text]
  • Philadelphia, PA April 28-May 1, 2011
    American Association for the History of Medicine AAHM 2011 Annual Meeting Sheraton Society Hill Hotel, Philadelphia, PA April 28-May 1, 2011 Table of Contents CME Information …………………………………………………………………………………...…...........2 Acknowledgements…………………………………………………………………………………...…..........3 AAHM Program Sessions ………………………………………………………………………………....4-12 Affiliated Societies‘ Schedules …………………………………………………………………………....13-18 AAHM Officers ………………………………………………………………………………………...........19 AAHM Council ……………………………………………………………………………………................19 2011 Meeting Committee …………………………………………………………………………….............19 Maps …………………………………………………………………………………………………......20-22 Advertisements ………………………………………………………………………………………......23-26 Abstracts ………………………………………………………………………………………………..27-151 Notes ………………………………………………………………………………………………….152-156 Future AAHM Meeting Sites ………………………………………………………………………….........157 Conference Hotel Sheraton Society Hill 1 Dock Street Philadelphia, PA 19106 (215) 238-6000 Other Locations The Fielding H. Garrison Lecture and Reception will be held at the National Constitution Center 525 Arch Street Philadelphia, PA 19106 (215) 409-6600 Registration Book Exhibit (Foyer BCD) (Hamilton Room) Thursday, April 28, 12:00 PM-7:00 PM Thursday, April 28, 6:30 PM-9:00 PM Friday, April 29, 7:00 AM-5:00 PM Friday, April 29, 9:00 AM-5:30 PM Saturday, April 30, 7:00 AM-5:00 PM Saturday, April 30, 9:00 AM-6:00 PM Sunday, May 1, 9:00 AM-12:00 PM Cover Image: DR. MCMUNN‘S KINATE OF QUININE AND CINCHONINE, C. 1862–67 ANONYMOUS (AMERICAN, ACTIVE MID-1860S); PRINTED COURTESY OF THE WILLIAM H. HELFAND COLLECTION, PHILADELPHIA MUSEUM OF ART 84th Annual Meeting of the American Association for the History of Medicine Conference Abstract & Program Book April 28 - May 1, 2011 Sheraton Society Hill Hotel Philadelphia, PA Continuing Education Credit Information CONTINUING MEDICAL EDUCATION CREDITS Continuing medical education credit for the AAHM meeting will be offered by, The School of Medicine, State University of New York at Stony Brook.
    [Show full text]
  • Proceedings – Small Animals
    22nd Annual Scientific Meeting Ergife Palace Hotel, Rome, Italy Proceedings – Small Animals Edited by: Stephen Baines and Martin Owen July 4–6, 2013 Welcome to Rome, welcome to Italy A Warm Welcome to Rome! Dear ECVS Diplomates, residents and colleagues Rome is the place to see! Rome, one of the most famous and historical cities in the southern part of Europe – one of the most important ancient cultural centres of Europe - offers a variety of architectural, cultural and historical highlights. Rome is easily accessible by train and car and by direct flights from most cities in Europe and the rest of the world. Further, we have the marvellous opportunity to host the scientific part of the congress in the Ergife Palace Hotel where all delegates have the possibility to stay. We were able to negotiate very favourable rates and we hope that delegates as well as exhibitors and sponsors will profit from this exceptional deal. The Ergife Palace Hotel caters for all our needs and wishes. It has modern equipped lecture halls that can host the three parallel small animal and the large animal session, and plenty of small lecture rooms and meeting spaces for side events and discussion groups. There is ample space for a large number of exhibitors and lots of space for the luncheon and coffee breaks The scientific programme will feature state-of-the-art lectures and in-depth seminars, for large and small animal specialists, a short communication section, the Residents’ forum and poster presentations. Invited speakers from all over the world, who are established specialists in their field, will present seminars and state-of-the-art lectures.
    [Show full text]
  • Eine Analyse Von Schulbüchern Im Fach Biologie
    Wissenschaftsgeschichte im Unterricht Eine Analyse von Schulbüchern im Fach Biologie Dissertation zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.) vorgelegt dem Rat der Biologisch-Pharmazeutischen Fakultät der Friedrich-Schiller-Universität Jena von: Michael Markert, M. Sc. geboren am: 17. Februar 1981 in: Saalfeld Gutachter 1. Gutachter und Betreuer: Prof. Dr. Uwe Hoßfeld (Jena) 2. Gutachter: Prof. Dr. Hans Peter Klein (Frankfurt am Main) 3. Gutachter: Prof. Dr. Georgy S. Levit (Halifax, Jena) Datum der Disputation 17. Dezember 2012 Inhaltsverzeichnis Abbildungsverzeichnis 6 Tabellenverzeichnis 7 Abkürzungsverzeichnis 8 1 Einleitung 9 2 Der Publikumsdiskurs im Fach Wissenschaftsgeschichte 16 2.1 Überblick ................................... 16 2.2 Fachselbstverständnis ............................. 18 2.2.1 Vergangenheit... ............................ 18 2.2.2 ...und Gegenwart ........................... 22 2.3 Wissenschaftsgeschichte und Öffentlichkeit ................. 25 2.3.1 Das Publikum (in) der Wissenschaftsgeschichte .......... 25 2.3.2 Die Auseinandersetzung mit ‚populärer‘ Wissenschaftsgeschichte . 28 2.3.3 Wissenschaftsgeschichte in der naturwissenschaftlichen Ausbildung 33 2.4 Zusammenfassung ............................... 37 3 Naturwissenschaftliche Bildung - Eine Annäherung 40 3.1 Konzepte .................................... 40 3.1.1 „Deficit model“ und „contextual model“ .............. 40 3.1.2 Das Konzept der „nature of science“ (NOS) ............ 48 3.2 Forschungsverständnisse in der Wissenschaftspädagogik
    [Show full text]